U.S. Physical Therapy, Inc. - Q1 2003 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2003. U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics providing pre- and post-operative care. As of the reporting date, the company operated 212 clinics across 34 states and managed five third-party facilities. The company utilizes a partnership structure for many clinics, though it is increasingly developing wholly-owned clinics due to changes in accounting practices regarding minority interests.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 |
|---|---|---|
| Net Revenues | $25.0 million | $22.3 million |
| Net Income | $1.8 million | $2.1 million |
| Diluted EPS | $0.15 | $0.16 |
| Operating Cash Flow | $3.7 million | $2.9 million |
| Cash and Equivalents | $10.1 million | $10.3 million (end of period) |
| Debt (Convertible Notes) | $2.3 million | $2.3 million |
| Current Ratio | 6.88:1 | 8.10:1 (Dec 31, 2002) |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 12% to $25.0 million, driven by a 12% increase in patient visits (265,000 vs. 237,000) and a slight increase in revenue per visit.
- Profit Decline: Despite revenue growth, net income fell 14% to $1.8 million. This was primarily due to a 27% increase in corporate office costs and rising clinic operating expenses.
- Cost Pressures: Clinic operating costs rose to 71% of revenues (from 68% in 2002). Salaries increased 15% due to staffing needs and bonuses, while rent and supplies increased 25%.
- Efficiency Gains: The provision for doubtful accounts decreased 22% to $338,000, reflecting improved collection efforts at mature clinics.
Outlook, Risks, and Management Commentary
- Expansion Plans: Management aims to open 40 to 45 new clinics in 2003. New clinics are expected to incur initial operating losses, negatively impacting short-term margins.
- Medicare Cap Risk: A significant risk is the implementation of the Medicare annual reimbursement cap ($1,590 per patient) effective July 1, 2003. Management estimates this could reduce 2004 income by up to 10% if not mitigated by secondary insurance or legislative repeal.
- Liquidity: The company maintains strong liquidity with $10.1 million in cash and no credit lines. It plans to fund operations and expansion through existing cash flows.
- Debt Maturity: The company holds $2.3 million in 8% Convertible Subordinated Notes due June 30, 2004. Repayment in cash will be required if the stock price is below the conversion price of $3.33 at maturity.
- Accounting Changes: New accounting rules (EITF 00-23) require expensing certain minority interest profits as compensation, prompting a strategic shift toward wholly-owned clinics.
Investor Verification Checklist
- Verify the impact of the July 1, 2003 Medicare reimbursement cap on projected 2004 revenues.
- Monitor the conversion status of the $2.3 million Series C Note due in June 2004 relative to the stock price.
- Assess the ramp-up time and profitability timeline for the 40-45 new clinics planned for 2003.
- Review the trend in corporate office costs, which rose 27% year-over-year.
- Confirm the company's ability to maintain liquidity without external credit lines as expansion continues.